GS 840 oral prodrug: GILD began a Phase II/III trial

Gilead Sciences Inc. (GILD), Foster City, Calif. Product: GS 840 oral prodrug, nucleotide inhibitor of HIV reverse transcriptase Indication: HIV Status: GILD began a Phase II/III trial of GS 840 in 4...